INSIGHTS ON DRUG DEVELOPMENT

• Key Metrics In Antibody Drug Development

  Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.

• Thermofluor Screening For Injectable Protein Formulations

  The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

• Solid State Hydrogen Deuterium Exchange To Study Antibody Drug Conjugate Stability

  Discover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based antibody drug conjugates and enhance ADC development processes.

• Predictive Human Biology At Scale

  Watch to explore applications of the Colon Intestine-Chip in studying cytokine-mediated inflammation, the effectiveness of anti-inflammatory therapies, and forthcoming immune cell recruitment.

• Improving In Vitro Cancer Modeling

  8/2/2024

  Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.

• Process Intensification: Your Guide To "Doing More With Less"

  8/5/2025

  Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

• Temperature Dependence On Reversed-Phase Separations

  7/17/2025

  Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.

• Validating Antibodies With Knock-Out Technologies

  10/8/2024

  Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.

• Navigating The Regulatory Space To Biosimilar Approval

  9/1/2025

  The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.